ARIES PHARMACEUTICALS, INC.
SAN DIEGO, CA

ARIES PHARMACEUTICALS, INC., SAN DIEGO

Learn more about our product pipeline: View Product Pipeline Our Company Aries Pharmaceuticals, Inc. (Aries) is a wholly owned subsidiary of Aries Pharmaceuticals, Ltd., which is a wholly owned Subsidiary of Cosmo Pharmaceuticals, NV, a specialty pharmaceutical and medical device company focused on developing and commercializing best in class products in endoscopy and to treat gastrointestinal diseases. The Aries portfolio of four products, three of which are still in development, is licensed from Cosmo Pharmaceuticals N.V. to Aries Pharmaceuticals, Ltd. Our products have the potential to improve patient outcomes in endoscopy and in the treatment of select gastrointestinal disorders. Approved Product Our first marketed product in the U.S., Eleview Products in Development *Methylene Blue MMX, Rifamycin SV MMX and Remimazolam are under investigation and the safety and effectiveness of the product(s) has not been established.

KEY FACTS ABOUT ARIES PHARMACEUTICALS, INC.

Company name
ARIES PHARMACEUTICALS, INC.
Status
Inactive
Filed Number
F17000001202
FEI Number
813494081
Date of Incorporation
March 14, 2017
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://ariespharmaceuticals.com
Phones
(858) 202-6122

ARIES PHARMACEUTICALS, INC. NEAR ME

Principal Address
9276 SCRANTON ROAD, SUITE 600,
SAN DIEGO,
CA,
92121,
US
Mailing Address
C/O BELLATRIX 4940 CARROLL CANYON ROAD,
#110,
SAN DIEGO,
CA,
92121

See Also

Officers and Directors

The ARIES PHARMACEUTICALS, INC. managed by the three persons from DUBLIN 2, SAN DIEGO on following positions: Director, PCEO

Hans Christoph Tanner

Position
Director Active
From
DUBLIN 2, ,

Niall Donnelly

Position
Director Active
From
DUBLIN 2, ,

Thomas Joyce

Position
PCEO Active
From
SAN DIEGO, CA, 92121




Events

March 20, 2020
WITHDRAWAL

Annual Reports

2019
April 10, 2019
2018
May 1, 2018